Australia - Hospital Average Length of Stay for Malignant Neoplasm of Prostate
Since 2014, Australia Hospital Average Length of Stay for Malignant Neoplasm of Prostate fell by 2.8% year on year. At 3.9 Days in 2019, the country was ranked number 29 among other countries in Hospital Average Length of Stay for Malignant Neoplasm of Prostate. Australia is overtaken by Norway, which was ranked number 28 with 4 Days and is followed by Denmark with 3.1 Days. South Korea topped the ranking with 15.9 Days in 2019, stable versus 2018. New Zealand, Lithuania and Slovakia respectively ranked number 2, 3 and 4 in this ranking. New Zealand witnessed the best average annual growth at +2.2% per year, while Mexico witnessed the worst performance at -8.8% per year.
Loading...
| Date | Days |
|---|---|
| 2019 | 3.90 |
| 2018 | 4.00 |
| 2017 | 4.20 |
| 2016 | 4.20 |
| 2015 | 4.60 |
Download all data from 1993 to 2019
How does Australia rank in Hospital Average Length of Stay for Malignant Neoplasm of Prostate?
| # | 32 Countries | Days | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
South Korea
|
15.90 | 2019 | +0.0 % | -0.9 % | View data | |
| 2 |
#2
New Zealand
|
11.60 | 2019 | -0.8 % | +2.2 % | View data | |
| 28 |
#28
Norway
|
4.00 | 2019 | +5.3 % | -0.5 % | View data | |
| 29 |
#29
Australia
|
3.90 | 2019 | -2.5 % | -2.8 % | View data | |
| 30 |
#30
Denmark
|
3.10 | 2019 | -3.1 % | -4.0 % | View data | |